Ca2+ dysregulation in the endoplasmic reticulum related to Alzheimer's disease: A review on experimental progress and computational modeling

Biosystems. 2015 Aug:134:1-15. doi: 10.1016/j.biosystems.2015.05.003. Epub 2015 May 19.

Abstract

Alzheimer's disease (AD) is a devastating, incurable neurodegenerative disease affecting millions of people worldwide. Dysregulation of intracellular Ca(2+) signaling has been observed as an early event prior to the presence of clinical symptoms of AD and is believed to be a crucial factor contributing to its pathogenesis. The progressive and sustaining increase in the resting level of cytosolic Ca(2+) will affect downstream activities and neural functions. This review focuses on the issues relating to the increasing Ca(2+) release from the endoplasmic reticulum (ER) observed in AD neurons. Numerous research papers have suggested that the dysregulation of ER Ca(2+) homeostasis is associated with mutations in the presenilin genes and amyloid-β oligomers. These disturbances could happen at many different points in the signaling process, directly affecting ER Ca(2+) channels or interfering with related pathways, which makes it harder to reveal the underlying mechanisms. This review paper also shows that computational modeling is a powerful tool in Ca(2+) signaling studies and discusses the progress in modeling related to Ca(2+) dysregulation in AD research.

Keywords: Alzheimer’s disease; Amyloid-β; Ca(2+) dysregulation; Computational modeling; Endoplasmic reticulum; Systems biology.

Publication types

  • Review

MeSH terms

  • Alzheimer Disease / metabolism*
  • Calcium / metabolism*
  • Calcium Signaling
  • Computational Biology*
  • Endoplasmic Reticulum / metabolism*
  • Homeostasis
  • Humans
  • Presenilins / genetics
  • Presenilins / metabolism

Substances

  • Presenilins
  • Calcium